PubMed:28549415 / 533-611
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T121 | 28-31 | UBERON:2001977 | denotes | PAD |
| T140 | 28-32 | PR:O24616 | denotes | PAD2 |
| T141 | 28-32 | PR:Q08642 | denotes | PAD2 |
| T142 | 28-32 | PR:000012220 | denotes | PAD2 |
| T143 | 28-32 | PR:P20717 | denotes | PAD2 |
| T144 | 28-32 | PR:P46309 | denotes | PAD2 |
| T145 | 28-32 | PR:Q8WR51 | denotes | PAD2 |
| T146 | 28-32 | PR:Q9Y2J8 | denotes | PAD2 |
| T147 | 45-69 | D018270 | denotes | mammary ductal carcinoma |
| T148 | 45-69 | D018270 | denotes | mammary ductal carcinoma |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 0-78 | DRI_Outcome | denotes | For our study, we modulated PAD2 activity in mammary ductal carcinoma cells by |